pCMV4a-SIRT2-Flag Citations (2)
Originally described in: A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity.Jing H, Hu J, He B, Negron Abril YL, Stupinski J, Weiser K, Carbonaro M, Chiang YL, Southard T, Giannakakou P, Weiss RS, Lin H Cancer Cell. 2016 Mar 14;29(3):297-310. doi: 10.1016/j.ccell.2016.02.007. PubMed Journal
Articles Citing pCMV4a-SIRT2-Flag
Articles |
---|
Effects of Dimerization on the Deacylase Activities of Human SIRT2. Yang J, Nicely NI, Weiser BP. Biochemistry. 2023 Dec 5;62(23):3383-3395. doi: 10.1021/acs.biochem.3c00381. Epub 2023 Nov 15. PubMed |
Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development. Kim G, Bhattarai PY, Lim SC, Lee KY, Choi HS. Cell Oncol (Dordr). 2023 Dec 19. doi: 10.1007/s13402-023-00910-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.